(Q37055354)

18 August 2017

1 reference

title

Gene polymorphisms in bladder cancer (English)

1 reference

18 August 2017

Maria Franekova

1

1 reference

18 August 2017

Erika Halasova

2

1 reference

18 August 2017

Eva Bukovska

3

1 reference

18 August 2017

Jan Luptak

4

1 reference

18 August 2017

Dusan Dobrota

5

1 reference

18 August 2017

publication date

29 October 2007

1 reference

18 August 2017

1 reference

18 August 2017

volume

26

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

1-8

1 reference

Chemotherapy and management of bladder tumours.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in DNA repair and metabolic genes in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic variability in susceptibility and response to toxicants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Pharmacogenetics of the major polymorphic metabolizing enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

NAT2 gene polymorphism in bladder cancer: a study from North India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Gender-specific effects of NAT2 and GSTM1 in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Glutathione-S-transferase family of enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Quinone reductases multitasking in the metabolic world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

An association between NQO1 genetic polymorphism and risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

CYP2E1 and NQO1 genotypes, smoking and bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Human sulfotransferases and their role in chemical metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Pharmacogenetics of human cytosolic sulfotransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

A myeloperoxidase polymorphism associated with reduced risk of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic testing for enzymes of drug metabolism: does it have clinical utility for pain medicine at the present time? A structured review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

How does a cell repair damaged DNA?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in XPD exons 10 and 23 and bladder cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

XRCC3 polymorphisms and risk of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

XRCC1 and DNA strand break repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: a mini review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

E-cadherin in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

E-cadherin gene polymorphism and risk of urothelial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Association Between A C/A Single Nucleotide Polymorphism of the E-Cadherin Gene Promoter and Transitional Cell Carcinoma of the Bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Blocking oncogenic Ras signaling for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

The p53 pathway in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

p53 codon 72 polymorphism and its association with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Distributions of p53 codon 72 polymorphism in bladder cancer--proline form is prominent in invasive tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms in GSTT1 and p53 and urinary transitional cell carcinoma in south-western Taiwan: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

A functional polymorphism in RGS6 modulates the risk of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.10.011

10.1016/J.UROLONC.2006.10.011

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference